Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study (Q33372501)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study |
scientific article |
Statements
1 reference
Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study (English)
1 reference
Gaia Schiavon
1 reference
Marisa Di Seri
1 reference
Vladimir Virzí
1 reference
Bruno Spalletta
1 reference
31 August 2006
1 reference
1 reference
59
1 reference
613-620
1 reference
Identifiers
1 reference
1 reference